This helps lower blood sugar without typically causing hypoglycemia, which is why GLP-1 therapy can be used in both diabetic and some non-diabetic patients
A 2023 study in Obesity reinforced this, noting that participants on GLP-1s lost significant amounts of fat-free mass if they were not concurrently engaging in resistance training or consuming sufficient dietary protein
MedVi's cash-pay model eliminates the insurance variable completely
MNT had the opportunity to speak with Babak Firoozi, MD, a board certified gastroenterologist at MemorialCare Orange Coast Medical Center in Fountain Valley, CA, about this study
Fund Details Issuer Roundhill Investments Fund Name Roundhill GLP-1 & Weight Loss ETF Tax Classification Regulated Investment Company Stock Exchange NASDAQ Current Symbol NASDAQ:OZEM Inception Date 5/20/2024 Fund Manager Will Hershey, Tim Maloney, Dave Mazza, Drew Walsh Previous Symbol NASDAQ:OZEM Web N/A Phone N/A Fund Focus Asset Class Equity Benchmark N/A Category Strategy Focus Theme Development Level Blended Development Region Global Number of Holdings 53 Fund Statistics Assets Under Management $0.00 Average Daily Volume $0.00 Discount/Premium 0.00% Administrator, Advisor and Custodian Administrator U.S